Contact

Representative before the EPO

Employment test 1 - 10 employees
Company dna konig szynka tilmann von renesse
operating since 1997
Headquarter in Munich and 1 office
active in Legal Services and IP Portfolio Processing

Lars Hemsath has worked on the following 4 EPO patent applications which have been published in the last five years:

EP13739973

NOVEL THERAPEUTIC TREATMENTS WITH ANTI-HER2 ANTIBODIES HAVING A LOW FUCOSYLATION

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14724007

ANTI-CANCER TREATMENTS WITH ANTI-EGFR ANTIBODIES HAVING A LOW FUCOSYLATION

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION REQUESTED
EP16168841

IMPROVED RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE

IPC classification:
A61K 38/00, A61K 38/24, C07K 14/435, C07K 14/59
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION REQUESTED
EP15719165

CONTROLLED OVARIAN HYPERSTIMULATION WITH IMPROVED RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE

IPC classification:
A61K 38/24, A61P 15/08
Applicant:
Glycotope GmbH
Agent:
Lars Hemsath, König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature